Pharmaceutical Ingredients
Home / Products / 
What we are
We are the leading manufacturer & exporter of a broad ranger of pharmaceutical intermediates which are extensively used in various pharmaceutical companies & research laboratories. Using high quality chemicals these intermediates are manufactured which ensure efficacy and no side effect on human health. We offer standard as well as customized packaging on these products to exactly meet the users requirements specifications.
Intermediate List
| Intermediate Name | Code | CAS NO | API/ END USE |
|---|---|---|---|
| 6-bromonicotinaldehyde | BNA-2 | 149806-06-4 | Abemaciclib |
| 5-((4-ethylpiperazine-1yl) methyl)pyridin-2amine | AMC-2 | 1180132-17-5 | |
| 6-bromo-4-fluoro-1-isopropyl-2-methyl-1h-benzo[d]imidazole | AMA-2 | 1231930-33-8 | |
| 4-fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | AMA-3 | 1231930-37-2 | |
| N,N-Dimethyl-3-phenyl-3-(O-tolyloxy)propan-1-amine oxalate | DPPO-3 | 107688-86-8 | Atomoxetine |
| (R)-3-Amino-piperidine dihydrochloride | CNOP-6 | 334618-23-4 | Alogliptin Linagliptin Trelagliptin |
| (R)-3-(Boc-Amino)piperidine | BCN-4 | 309956-78-3 | |
| 2-(Chloromethyl)-4-methylquinazoline | CMQ-1 | 109113-72-6 | |
| 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine | BBX-2 | 666816-98-4 | |
| Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl)butanoate | DAM-3 | 3543-72-4 | Bendamustine |
| Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2-yl)butanoate | DAM-4 | 3543-73-5 | |
| Isopropyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate | BEN-4 | 1313020-26-6 | |
| 2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone / CGF-3 | CGF-3 | 32384-65-9 | Canagliflozin Dapagliflozin Empagliflozin |
| 4-chloro-6,7-dimethoxyquinoline | CAB-4 | 35654-56-9 | Cabozantinib |
| 4- Guanidinobenzoic Acid HCl | GBA HCl | 42823-46-1 | Camostat mesylate |
| 2-Chloro-N,N-dimethylacetamide | CST-1 | 2675-89-0 | |
| 4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester | CST-2 | 59721-16-3 | |
| 3-(3-Trifluoromethylphenyl)propionic Acid | TPA-2 | 585-50-2 | Cinacalcet |
| (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide | CNC | 1005450-55-4 | |
| 4-(4-Chlorophenyl)-1H-benzo[D][1,2]oxazin-1-one | CLT-1 | 2224-83-1 | Chlorthalidone |
| 3-(4'-chlorophenyl) phthalimidine | CLT-2 | 2224-77-3 | |
| 4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene | BDG-2 | 461432-23-5 | Dapagliflozin |
| 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene | IDG-2 | 1103738-29-9 | |
| N-(2-Hydroxyethyl) succinimide | HDS-1 | 18190-44-8 | Diroximel |
| Ethyl 3(-4-(ethyl amino)-3- nitro-N-(pyridin-2-yl)benzamido)propanoate | DG-2 | 429659-01-8 | Dabigatran |
| Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate | CBA-3G | 212322-56-0 | |
| 2-(4-Cyanophenylamino) Acetic Acid | CBA-4 | 42288-26-6 | |
| Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H-benzimidazol-5-yl]carbonyl]pyridine-2-ylamino] propionate. | DBG-1 | 211915-84-3 | |
| Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride. | DBG-2 | 211914-50-0 | |
| ethyl 3-[[2-(chloromethyl)-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate | DAB-1 | 1307233-94-8 | |
| Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl) phenyl) amino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d] imidazole-5-carboxamido) propanoate | DAB-2 | 211915-06-9 | |
| Hexyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride | NAR-2 | 1307233-93-7 | |
| 2-(N-BOC)-Aminothiazole-5-carboxylic acid | DTB-3 | 302964-02-9 | Dasatinib |
| (E)-N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide | ATC-2 | 863127-76-8 | |
| 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | ATC-3 | 302964-24-5 | |
| 4,6-dichloro-2-methylpyrimidine | PMD-2 | 1780-26-3 | |
| N-Boc-D-phenyl glycinol | RPG-2 | 102089-74-7 | Elagolix |
| (R)-2-(tert-butoxycarbonylamino)-2-phenylethyl methanesulfonate | RPG-3 | 102089-75-8 | |
| 1,3-dimethyl-1H-pyrazole-4-sulfonamide | DPS2 | 88398-53-2 | Elexacaftor |
| 2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde | DBD | 29668-44-8 | Eliglustat |
| (S)-(+)-2-Phenylglycinol | ELG | 20989-17-7 | |
| (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran | BEG-3 | 915095-89-5 | Empagliflozin |
| (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran | EG-3 | 915095-94-2 | |
| 6,7-Dihydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin-4-one | ENS-2 | 76536-66-8 | Ensifentrine |
| 4-(chloromethyl)-1-cyclopentyl 2-(trifluoromethyl)benzene | CCB2 | 957208-65-0 | Etrasimod |
| ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate | ETC5 | 1206124-13-1 | |
| 3-(N-Methyl-N-Pentyl amino)propionic acid HCl | IBA3 | 625120-81-2 | Ibandronate |
| 4-Aminopyrazolo[3,4-d]pyrimidine | IBT-3P | 2380-63-4 | Ibrutinib |
| 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | PPA-2 | 330786-24-8 | |
| (ethane-1,2-diylbis(oxy)) bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate) | ICT-1 | 19249-03-7 | Icotinib |
| 4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride | MPB-2 | 106261-49-8 | Imatinib |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | IMA-5 | 152460-10-1 | |
| Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate | IVF-2 | 52980-28-6 | Ivacaftor |
| 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (USDMF No. 35586) | IVF-3P | 13721-01-2 | |
| 5-Amino-2,4-ditert-butylphenol | ABN2 | 873055-58-4 | |
| 4-(chloroacetyl)-morpholine | CME | 1440-61-5 | Lesinurad |
| 4-Chloro-1-(4-fluorophenyl)butan-1-one | LMT-1 | 3874-54-2 | Lumateperone |
| 2-(2-Aminothiazol-4-yl)acetic acid | ATA-2 | 29676-71-9 | Mirabegron |
| 2-(2-Aminothiazol-4-yl)acetic acid hydrochloride | ATA-2 HCL | 66659-20-9 | |
| 2-(4-nitrophenyl)ethanamine hydrochloride | MRG-2 | 29968-78-3 | |
| (R)-2-(4-nitrophenethylamino)-1- Phenylethanol (USDMF No 35841 ) | MRG-4 BASE | 223673-34-5 | |
| (R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride | MRG-4 | 521284-21-9 | |
| (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | MRG-5 BASE | 391901-45-4 | |
| (R)-2-(4-aminophenethylamino)-1-Phenylethanol hydrochloride | MRG-5 | 521284-22-0 | |
| Etyl-3-guanidino-4-methyl-benzoate nitrate | NTB-4 | 641569-96-2 | Nilotinib |
| 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline | NTA-2 | 641571-11-1 | |
| 3-dimethylamino-1-(3-pyridyl)-2-propen-1-one | IMA-3 | 55314-16-4 | |
| 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid | NTC | 641569-94-0 | |
| 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one | MCZ | 27387-31-1 | Ondansetron |
| 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one HCl | MAN | 119812-29-2 | |
| L-Glutamic acid diethyl ester hydrochloride | GDE | 1118-89-4 | Pemetrexed |
| 2-[(4-Bromophenyl)methoxymethylene]propanedinitrile | BMP3 | 1188083-45-5 | Pirtobrutinib |
| 4-(6-Fluoro-1,2-benzisoxazole-3yl)-Piperidine Hydrochloride | PRSI-4 | 84163-13-3 | Paliperidone/ Risperidone |
| 4-[2,4-Difluoro benzoyl]Piperidine hydrochloride | PLP-2H | 106266-04-0 | |
| 3-(Benzyloxy)pyridine-2-amine | POL-1 | 24016-03-3 | |
| 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrididine-4-one | SPR2Base | 63234-80-0 | |
| 2-Benzyl acrylic acid | RAC-2 | 5669-19-2 | Racecadotril |
| Benzyl glycinate p-toluene sulfonate | RAC-3 | 1738-76-7 | |
| 3-Amino-6-methoxy pyridazine | AMP-2 | 7252-84-8 | Relugolix |
| Isonipecotamide /4-Piperidinecarboxamide | INA | 39546-32-2 | Revefenacin |
| 2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | RCP-4 | 1211443-61-6 | Ribociclib |
| Phenyl phenylcarbamate | RPT-1 | 4930-03-4 | Ripretinib |
| 4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | SITA2 | 764667-65-4 | Sitagliptin |
| 3-Quinuclidinone hydrochloride | RCN2 | 1193-65-3 | Solifenacin |
| 4-[2-hydroxyethyl]phenol | TRS-2 | 501-94-0 | Tyrosol |
| 4-chloro-7H-pyrrolo [2,3-d]pyrimidine | PPC-2 | 3680-69-1 | Tofacitinib Barcitinib Ruxolitinib |
| 4-bromo-7Hpyrrolo[2,3D]pyrimidine | ITB-3 | 889939-42-8 | |
| 2,4-Dichloro-1H-pyrrolo[2,3-D]pyrimidine | TDC | 90213-66-4 | |
| 3-Cyclopentylacrylonitrile | CPA | 591769-05-0 | |
| Cyclopentanecarboxaldehyde | CPC | 872-53-7 | |
| Bromoacetaldehyde Diethyl Acetal | DEDA | 2032-35-1 | |
| 2-Bromo-1,1-dimethoxyethane | DMDA | 7252-83-7 | |
| Formamidine acetate | FOA | 3473-63-0 | |
| 1,4,7-Trimethyl-1,4,7-Triazacyclononane | TMT4 | 96556-05-7 | Others |
| BOC-L-Glutamine | NBG | 13726-85-7 | |
| (S)-Dimethyl 2-((tert-butoxycarbonyl)amino)pentanedioate | BGM-2 | 59279-60-6 | |
| 1-Methylpiperidine-4-carboxamide | MPC-2 | 62718-28-9 | |
| 1-methylpiperidine-4-carbonitrile | MPC-3 | 20691-92-3 | |
| (1-Methylpiperidin-4-Yl)Methanamine | MPC-4 | 7149-42-0 |
Note: All Transactions are carried out in conformity with patent laws applicable in the buyer’s country. Responsibility with respect to third parties’ patent rights in a specific country lies exclusively with the buyer
